BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2264163)

  • 1. Autoantibodies in cyclosporine A-induced autoimmune disease.
    Wodzig KW; Majoor GD; van de Gaar MJ; van Breda Vriesman PJ
    Transplant Proc; 1990 Dec; 22(6):2586-7. PubMed ID: 2264163
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclosporin-induced autoimmunity: a role for marrow-derived cells presenting self antigens in the thymus.
    Babcock SK; Georgiu H; Kotzin B; Bellgau D
    Transplant Proc; 1989 Feb; 21(1 Pt 1):220-1. PubMed ID: 2650108
    [No Abstract]   [Full Text] [Related]  

  • 3. Malignant neoplasms in cyclosporine-induced autoimmunity.
    Wodzig KW; Majoor GD; Tiebosch AT; de Heer E; van Breda Vriesman PJ
    Transplant Proc; 1993 Oct; 25(5):2816-8. PubMed ID: 8212246
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclosporin A induces a selective, reversible suppression of T-helper lymphocyte regeneration after syngeneic bone marrow transplantation: association with syngeneic graft-versus-host disease in rats.
    Bos GM; Majoor GD; van Breda Vriesman PJ
    Clin Exp Immunol; 1988 Dec; 74(3):443-8. PubMed ID: 2976623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine-induced syngeneic graft-versus-host disease: assessment of T cell differentiation.
    Hess AD; Vogelsang GB; Heyd J; Beschorner WE
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2683-6. PubMed ID: 3547947
    [No Abstract]   [Full Text] [Related]  

  • 6. Perturbation of T-cell differentiation in lethally irradiated rats reconstituted with syngeneic bone marrow and treated with cyclosporin-A.
    Bos GM; Majoor GD; Van Breda Vriesman PJ
    Thymus; 1989; 14(1-3):155-61. PubMed ID: 2516375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ciclosporin treatment in experimental autoimmune myasthenia gravis.
    Gunn HC; Hiestand PC; Hanglow AC
    Monogr Allergy; 1988; 25():96-107. PubMed ID: 3262820
    [No Abstract]   [Full Text] [Related]  

  • 8. Cyclosporine-induced syngeneic graft-versus-host disease: recognition of self MHC class II antigens in vivo.
    Hess AD; Horwitz LR; Laulis MK
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1218-21. PubMed ID: 8442094
    [No Abstract]   [Full Text] [Related]  

  • 9. Allogeneic small bowel transplantation with cyclosporine and donor whole-body irradiation.
    Frantz FW; Terris DJ; Wyble CW; Halperin EC; Sanfilippo F; Scroggs MW; Honoré G; Bollinger RR
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):193-6. PubMed ID: 3279610
    [No Abstract]   [Full Text] [Related]  

  • 10. Demonstration of strong classic immune reactivity after total-body irradiation for bone marrow transplantation. Implications for human T-depleted bone marrow transplantation.
    Gassmann W; von Kolszynski M; Wottge HU; Müller-Ruchholtz W
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2687-8. PubMed ID: 3079091
    [No Abstract]   [Full Text] [Related]  

  • 11. Cyclosporin A-induced autoimmune disease in mice.
    Bucy RP; Xu XY; Li J; Huang G
    J Immunol; 1993 Jul; 151(2):1039-50. PubMed ID: 8335890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunopathology of rat thymus after cyclosporine A.
    Beschorner WE; Namnoum JD; Hess AD
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1230-5. PubMed ID: 3547857
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapamycin effects on immunologic reconstitution.
    Vogelsang GB; Hess AD
    Transplant Proc; 1993 Feb; 25(1 Pt 1):727-8. PubMed ID: 8438459
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolongation of cardiac allograft survival by pretransplant administration of cyclosporine and donor-specific dendritic cells.
    Choti M; Lenrow D; Roza A; Markmann J; Naji A
    Transplant Proc; 1989 Feb; 21(1 Pt 1):478-9. PubMed ID: 2565055
    [No Abstract]   [Full Text] [Related]  

  • 15. Total lymphoid irradiation and cyclosporine prolongs cardiac allograft survival in the sensitized rat model.
    Harland RC; Halperin EC; Yamaguchi Y; Ruiz P; Scroggs MW; Sanfilippo F; Bollinger RR
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1118-9. PubMed ID: 2650071
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunological mechanisms governing tolerance to self-major histocompatibility complex antigens after bone marrow transplantation.
    Hess AD; Fischer AC; Horwitz LR; Bright EC; Hess JM
    Transplant Proc; 1995 Feb; 27(1):1370-3. PubMed ID: 7878915
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic cyclosporine-induced autoimmune disease in the rat: a new experimental model for scleroderma.
    Bos GM; Majoor GD; Willighagen RG; van Breda Vriesman PJ
    J Invest Dermatol; 1989 Nov; 93(5):610-5. PubMed ID: 2794549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirements for the induction and adoptive transfer of cyclosporine-induced syngeneic graft-versus-host disease.
    Fischer AC; Beschorner WE; Hess AD
    J Exp Med; 1989 Mar; 169(3):1031-41. PubMed ID: 2647891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Total lymphoid irradiation.
    Sutherland DE; Ferguson RM; Simmons RL; Kim TH; Slavin S; Najarian JS
    Urol Clin North Am; 1983 May; 10(2):277-88. PubMed ID: 6344387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of V beta T-cell receptor repertoire of effector mechanisms in acute and chronic graft versus host disease.
    Fischer AC; Ruvolo PP; Horwitz LR; Hess AD
    Transplant Proc; 1995 Feb; 27(1):1366-9. PubMed ID: 7878914
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.